Join Now

Author Archives: Natalie Themm

Audio-based Detection of Anxiety and Depression via Vocal Biomarkers

By Natalie Themm | Published September 28, 2023

Audio-based Detection of Anxiety and Depression via Vocal Biomarkers

Posted in BioUtah News | Tagged | Comments Off on Audio-based Detection of Anxiety and Depression via Vocal Biomarkers

bioMérieux submits Dual 510(k) and CLIA-waiver application to FDA for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel

By Natalie Themm | Published September 28, 2023

Marcy-l’Étoile (France), September 22nd, 2023 – bioMérieux, a world leader in the field of in vitro diagnostics, has submitted the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel to U.S. Food and Drug Administration (FDA) for a dual 510(k) clearance and CLIA1-waiver. This panel is already CE-marked (IVDD2).

Posted in BioUtah News | Tagged | Comments Off on bioMérieux submits Dual 510(k) and CLIA-waiver application to FDA for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel

Rep. Moore’s Health Staff Visits Utah Life Sciences Companies

By Natalie Themm | Published September 21, 2023

Rep. Moore’s Health Staff Tours Visits Utah Life Sciences Companies

Posted in BioUtah News | Comments Off on Rep. Moore’s Health Staff Visits Utah Life Sciences Companies

Partnership and innovation help SSM Health secure lower-cost, reliable supply of generic drugs

By Natalie Themm | Published September 21, 2023

Civica Rx, a health care utility co-founded by SSM Health, supplies critical medications that patients need.

Posted in BioUtah News | Tagged | Comments Off on Partnership and innovation help SSM Health secure lower-cost, reliable supply of generic drugs

GE HealthCare Awarded a $44 Million Grant to Develop Artificial Intelligence-Assisted Ultrasound Technology Aimed at Improving Outcomes in Low-and-Middle-Income Countries

By Natalie Themm | Published September 21, 2023

rant from Bill & Melinda Gates Foundation will facilitate development of AI-assisted applications and tools

Posted in BioUtah News | Tagged | Comments Off on GE HealthCare Awarded a $44 Million Grant to Develop Artificial Intelligence-Assisted Ultrasound Technology Aimed at Improving Outcomes in Low-and-Middle-Income Countries

BioUtah, Life Sciences Innovators Take Stage at Legislature’s Interim Meeting

By Natalie Themm | Published September 21, 2023

The Utah Life Sciences Innovation Caucus hosted a lunch for all legislators during the September 18.

Posted in BioUtah News | Comments Off on BioUtah, Life Sciences Innovators Take Stage at Legislature’s Interim Meeting

NUSANO APPOINTS INDUSTRY EXPERT ALEXANDRE GIBIM AS CHIEF OPERATIONS OFFICER

By Natalie Themm | Published September 21, 2023

EXECUTIVE WITH THREE DECADES OF SUCCESSFUL MULTINATIONAL OPERATIONS AND COMMERCIAL EXPERIENCE TO LEAD LAUNCH OF PROPRIETARY RADIOISOTOPE PRODUCTION PLATFORM

Posted in BioUtah News | Tagged | Comments Off on NUSANO APPOINTS INDUSTRY EXPERT ALEXANDRE GIBIM AS CHIEF OPERATIONS OFFICER

BioUtah Participates in American Cancer Society Policy Panel Presentation

By Natalie Themm | Published September 14, 2023

Kelvyn Cullimore, BioUtah’s CEO, participated as a panelist.

Posted in BioUtah News | Comments Off on BioUtah Participates in American Cancer Society Policy Panel Presentation

Merit Medical Launches the Aspira® Evacuated Drainage Bottle

By Natalie Themm | Published September 7, 2023

Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients

Posted in BioUtah News | Tagged | Comments Off on Merit Medical Launches the Aspira® Evacuated Drainage Bottle

Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection

By Natalie Themm | Published September 7, 2023

REC-3964 has been well tolerated in healthy volunteers with no reported serious adverse events. Recursion to explore initiating a Phase 2 proof-of-concept study in patients with recurrent Clostridioides difficile infection in 2024.

Posted in BioUtah News | Tagged | Comments Off on Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection

New Myriad Genetics Survey Reveals Widespread Confusion and Misconceptions About Ovarian Cancer Screening Among a Majority of Women

By Natalie Themm | Published September 7, 2023

Nearly three out of four women falsely believe a pap smear will reveal ovarian cancer presence

Posted in BioUtah News | Tagged | Comments Off on New Myriad Genetics Survey Reveals Widespread Confusion and Misconceptions About Ovarian Cancer Screening Among a Majority of Women

Myriad Genetics Named to 2023 Best Workplaces in Health Care List by Fortune and Great Place To Work

By Natalie Themm | Published September 7, 2023

Myriad Genetics announced Great Place To Work® and Fortune magazine have named Myriad Genetics to the 2023 Fortune Best Workplaces in Health Care™ List.

Posted in BioUtah News | Tagged | Comments Off on Myriad Genetics Named to 2023 Best Workplaces in Health Care List by Fortune and Great Place To Work

A Special Thanks To Our Legacy and Platinum Elite Members